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Abstract: In vitro three-dimensional models for metastatic ovarian cancer
have been useful for recapitulating the human disease. These spheroidal
tumor cultures, however, can grow in excess of 1 mm in diameter, which are
difficult to visualize without suitable imaging technology. Optical coherence
tomography (OCT) is an ideal live imaging method for non-perturbatively
visualizing these complex systems. OCT enabled detailed observations of
the model at both nodular and cellular levels, revealing growth dynamics not
previously observed. The development of a time-lapse OCT system, capable
of automated, multidimensional acquisition, further provided insights into
the growth and chemotherapeutic response of ovarian cancer.
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1. Introduction
A major challenge in the field of cancer research is the difficulty in observing the growth, de-
velopment, and treatment of microscale lesions in vivo. This limitation is especially evident
in epithelial ovarian cancer. One of the major problems in the treatment and management of
ovarian cancer is the lack of effective therapy for advanced metastatic disease, which is unfor-
tunately presented by over 70% of women at the time of diagnosis. Although ovarian epithelial
cancer is actually one of the most treatable solid tumors in its early stages, it is rarely detected at
that point as the disease is often asymptomatic when it starts in the ovaries. This cancer metas-
tasizes rapidly through an exfoliation process, where cancer cells are shed from the primary
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tumor into the peritoneal cavity to form micrometastatic lesions [1]. These microscopic metas-
tases, which grow along peritoneal surfaces, are exceedingly difficult to detect clinically with
existing technologies and are therefore often missed in the diagnosis and treatment of ovarian
cancer. As a result, little is known about the early development of these tumor nodules, and even
less is understood regarding their structural and molecular responses to therapeutic regimens.
A vast array of in vitro models for cancer growth and treatment have been developed to
mimic human disease, ranging from simple monolayer cell cultures to more complex tissue
constructs [2, 3, 4, 5] and animal models [6, 7, 8]. Traditional cell cultures are grown as a
two-dimensional monolayer and therefore lack the architectural cues that are critical for ac-
curately modeling tumor growth and treatment. Animal models, while excellent at recreating
tumor microenviroments, are typically costly and time-consuming, making large-scale thera-
peutic studies difficult. Three-dimensional in vitro models can address these limitations as they
are capable of recapitulating many of the cell-cell interactions needed to model tumor growth
and can be developed for high-throughput experiments. A promising in vitro model for cancer
studies is the multicellular tumor spheroid. These 3D culture systems are well established and
have been utilized in a wide array of cancer studies, including research on radiation therapies,
drug resistance, tumor invasion and angiogenesis, as well as high-throughput drug screening
programs [2, 3, 4, 5]. Recent research efforts utilize basement membrane substitutes to restore
some of the cellular signals observed in vivo [9]. In this “overlay” model, cells seeded onto the
surface of a matrix comprised of reconstituted basement membrane self-assemble to grow into
spheroidal tumor nodules called acini that sit atop the matrix bed. An ovarian cancer overlay
culture based on NIH OVCAR-5 cells generates acini that are similar in size and composition
to in vivo micrometastatic nodules, and grow along the matrix surface, providing a powerful
model for visualizing ovarian cancer tumor growth and treatment response [10].
In the early stages of in vitro growth, ovarian acini are small enough to be imaged using stan-
dard confocal imaging technology. However, as the acini mature, their diameters can range up
to 200 µm, beyond the imaging depth of confocal microscopes. Ongoing studies investigating
therapeutic regimens are generally carried out between one and two weeks of growth, at which
time the acini can reach 350 µm in size. By three weeks of tumor growth, acini can grow as
large as 1 mm in diameter with complex internal structures. These large spheroids, which sit
atop several hundred microns of gel matrix, become unfeasible to image even with advanced
multiphoton microscopy systems. This lack of suitable imaging technology has made it difficult
to visualize the important structural dynamics which occur in these complex tumor models.
An ideal approach for visualizing large, structurally complex three-dimensional models is
optical coherence tomography (OCT). OCT is a highly sensitive, cross-sectional imaging tech-
nique capable of visualizing the microscopic details of biological tissues. OCT has found ex-
tensive applications in fields such as ophthalmology [11, 12], cardiology [13], gastroenterology
[14, 15] and dermatology [16]. As the optical analog of ultrasound, OCT provides structural in-
formation based on the light reflected from objects in a sample. Current state-of-the-art spectral
domain OCT systems utilize large bandwidth light sources (>150 nm) capable of cellular-
resolution imaging. With penetration depths exceeding 1.5 mm, OCT is particularly apt for
visualizing even the largest 3D nodules. Most importantly, OCT is a non-perturbative imaging
technique. The standard methods for tumor spheroid imaging require fixation and staining [3],
which are highly perturbative, destructive and can introduce artifacts. With OCT imaging, cells
remain viable allowing for long-term, longitudinal three-dimensional visualization of acinar
growth and development. This gives OCT the potential to play a large role in understanding tu-
mor therapeutics, where current imaging approaches only capture temporal snapshots. Finally,
OCT is capable of fast imaging where the structure of dozens of acini can be captured in a
few seconds. This rapid image acquisition enables high-throughput imaging experiments for
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Fig. 1. Ultrahigh resolution OCT and multiphoton microscopy experimental setup. The out-
put from a Ti:Sapphire laser is either coupled into a fiber interferometer for OCT imaging
or selected with a flip mirror towards a pair of dispersion compensating mirrors (DSP) for
two-photon microscopy. The sample arm of the interferometer or the reflected dispersion
compensated beam was coupled into an inverted beam-scanning microscope. SL, scan lens;
TL, tube lens; DM, dichroic mirror; SM, silver mirror; PMT, photomultiplier tube.
drug screening applications. In this study, OCT will be shown as an ideal structural imaging
technology for visualizing three-dimensional tumor models, with the capability to carry out ex-
tended, time-lapse imaging of the complex structural dynamics underlying both tumor growth
and treatment response.
2. Experimental Methods
2.1. Ultrahigh resolution optical coherence tomography imaging system
Imaging experiments were performed on a custom-built, laser-scanning microscopy system
(Fig. 1). A broadband Ti:Sapphire laser (Integral OCT, Femtolasers) with a bandwidth of 190
nm centered at 850 nm and output power of 110 mW provided the light for both the ultra-
high resolution SD-OCT and two-photon imaging experiments. SD-OCT [17, 18] was chosen
for this experiment as it has the capability to be stable over several days of continuous, auto-
mated imaging. For the OCT system, the output of the Integral OCT was fiber coupled into
a SMF fiber (SMA 600) and entered into an 80:20 fiber interferometer (AC Photonics). The
80% arm of the interferometer was directed toward a reference arm, while the 20% arm was
directed towards the laser-scanning microscope. A pair of galvanometric mirrors (Cambridge
Technologies) were arranged in a 4f configuration to enable point-scanning of the beam in the
microscope focal plane. The scanned beam was directed into a Zeiss 200M inverted micro-
scope, reflected off a silver mirror (21004b, Chroma Technologies) mounted in the microscope
turret, and finally passed through an objective lens. A .15NA Zeiss 5X EC Plan Apo objective
was used for all OCT imaging sessions. The total power at the focus was 1.5 mW, and was
controlled by a neutral density filter wheel (Thorlabs) in the sample arm. The reflected light
from the microscope focal plane was combined with the light reflected from the reference arm
in the fiber interferometer and a portion of the interference was directed towards a custom-
built spectrometer. Light emerging from the fiber tip was first expanded with a telescope before
passing through a transmission grating (1200 lines/mm). The dispersed spectrum was focused
using a three-element lens with a focal length of 100 mm onto a Basler L104k 2048 element
line-scan camera capable of running at 29.3 kHz. The spectral range of the detector was set
to sample a spectral bandwidth of 122 nm. A National Instruments 1428 frame grabber board
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was used to read in the spectral from the line scan camera using the NI IMAQ interface. The
camera readout and galvanometric mirrors were controlled using home-built software. A Lab-
View front end provided user control of the imaging system, while custom multithreaded C
libraries called by LabView allowed for rapid Fourier Transforms via the Intel IPP libraries.
The software was run on an eight-core SignaTec computer utilizing a four-disk RAID array
for real-time processing, visualization, and storage of incoming camera data at the full camera
readout rate. The RAID array used in this experiment was comprised of four 750 GB, 7,500
RPM SATA II hard drives (Seagate Barracuda). For the OCT experiments here, the camera was
run at 20 kHz with an integration time of 50 µs. The spectrum was calibrated and remapped
for even spacing in frequency space using a coverslip placed between the laser aperture and the
fiber coupler. An iterative method was used to obtain the wavelength-dependent dispersion for
real-time compensation during data acquisition [19]. An axial resolution in tissue of 1.8µm (n
= 1.34) was measured at the -3 dB point by fitting a gaussian through the point spread function
derived from the reflection off a mirror in the sample arm. Using size-calibrated polystyrene
microspheres (Polysciences), the lateral resolution of the imaging system was found to be 6.7
µm. A temperature-controlled incubation stage (DH-35i, Warner Instruments) was mounted on
the microscope for imaging live samples.
2.2. Two-photon microscopy system
The free-space output of the Integral OCT was directed through a broadband dispersion mir-
ror pair (GSM201, Femtolasers), which provided -3500 fs2 of dispersion pre-compensation
for two-photon imaging experiments [20]. The pre-compensated beam was directed to the gal-
vanometric mirror pair described above, before being sent into the inverted microscope. A 700
nm long-pass filter (HQ700LP, Chroma Technologies) was positioned before the microscope
entrance to filter out the Ti:Sapphire superfluorescence. The beam was reflected towards the
objective lens by a short-pass dichroic mirror positioned in the microscope turret (675DC-
SPxr, Chroma Technologies). A .75NA Olympus 20X UPlanSApo UIS2 objective was used for
all multiphoton imaging experiments as it was found to have high infrared transmission and
low dispersion. The average power at the sample was 30 mW for all experiments. The lateral
and axial resolutions of the two-photon system were measured, using 200 nm size-calibrated
microspheres (Polysciences YG Fluoresbright Microspheres), to be 560 nm and 4.2 µm, re-
spectively, due to moderate beam astigmatism. The objective was screwed into a piezoelectric
stack mounted on the microscope nosepiece that was used for fine axial height adjustments
(PIFOC P-725.2CD, PI). Fluorescence generated in the focal volume was collected in the epi-
direction, and passed through a set of filters (HQ450/50X, HQ620/60M, Chroma Technologies)
before being focused by a 100 mm lens onto a photon-counting photomultiplier tube (H7421-
40, Hamamatsu). The photon counts generated by the H7421 PMT were acquired using a Na-
tional Instruments 6602 board. A LabView program was used to control the galvo mirrors and
read the photon counts. In addition to providing a live image of the sample, the program was
also made to collect z-stacks for three-dimensional imaging.
2.3. Time-lapse optical coherence tomography
For long-term time-lapse OCT imaging, alterations were made to the OCT system. In order to
have a stable spectrum for greater than 48 hours, the output of a Broadlighter D890HP (890 nm
centered, 90 nm bandwidth, Superlum) was used instead of the Ti:Sapphire. The spectrum was
found to be stable for over four days after a three-hour warm-up period. As the output power of
the combined diodes was only 3 mW, the acquisition speed of the OCT system was considerably
reduced to allow for 300 to 600 µs of spectral integration time. The lower bandwidth SLD
source resulted in an axial resolution in tissue of 3.7 µm (-3 dB, n = 1.34), while the lateral
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resolution was found to be 7.0 µm. A custom Labview program ran the time-lapse system
continuously, with volumes recorded at user-defined intervals. The power at the sample was
below 300 µW. The alignment of the spectrometer was checked regularly during time-lapse
experiments. An incubation chamber was built around the Warner Instruments temperature-
controlled stage to allow for longitudinal imaging of acinar growth and treatment dynamics.
Pre-mixed 95% air, 5% CO2 gas was passed through a Pyrex glass bubbler containing sterile
water maintained at 100 C providing humidity to slow the evaporation of sample media. Gas
flow was set to provide a slight positive pressure flow over the sample dish. A layer of mineral
oil (Sigma) was also poured on top of the media in the culture dish to slow evaporation while
allowing for gas exchange. As the cell media was supplemented with phenol red dye, the culture
media pH was checked by observing the media color under white light illumination on the
microscope.
The Live/Dead viability assay was purchased from Invitrogen and used according to the
supplied protocols. The viability marker used in this experiment was Calcein Green AM ester.
In its ester form, the calcein dye molecule is non-fluorescent and can easily permeate the cell
membrane. Inside the cytoplasm of a viable cell, cellular esterase enzymes act to cleave the ester
bond, converting calcein green AM into calcein, a polyanionic, fluorescent, and cell-membrane
impermeable dye. The conversion of calcein green AM to calcein by esterase activity leads to
the retention and build up of intracellular calcein, allowing the easy observation of cell viability.
The nuclei of non-viable were stained by ethidium bromide, which readily penetrates the dead
cells’ ruptured cell membranes and brightens upon DNA intercalation.
2.4. Three-dimensional ovarian acini culture
The three-dimensional ovarian cancer model was developed following a protocol similar to that
described in Debnath et al [3]. Human ovarian carcinoma cells (OVCAR-5 cell line, Fox Chase
Cancer Institute) derived from an untreated patient were used. OVCAR-5 cells were grown
and maintained in cell media composed of RPMI 1640 (CellGrow, Mediatech) supplemented
with 10% fetal bovine serum (Gibco) and 1% 5,000 I.U./ml penicillin/streptomycin (CellGrow,
Mediatech).
The three-dimensional tissue culture was created on the coverslip surface of 20 mm aperture
glass-bottomed 35 mm culture dishes (P35G-0-20-C, Mattek). This surface was evenly coated
with 150 µL of reduced growth factor reconstituted basement membrane (GFR Matrigel, BD
Biosciences). As Matrigel solidifies rapidly at room temperature, the coating protocol was car-
ried out on ice with all components chilled to 4 C or below. After 30 minutes of incubation at
37 C, 500 µL of a 15,000 cell/mL OVCAR-5 cell suspension in cell media was seeded over the
20 mm diameter Matrigel surface. The culture dishes were then incubated for 40 minutes at 37
C to allow for cell adhesion to the gel. After 40 minutes, the media volume in each culture dish
was brought to 2 mL and was supplemented with 2% GFR Matrigel. The culture dishes were
then maintained with 2% GFR Matrigel supplemented cell media for the duration of acinar
growth.
2.5. Immunofluorescence protocol and imaging method
Acini were stained following a protocol closely derived from Debnath et al. [3], with one major
exception. To prevent the degradation of the Matrigel during the staining protocol and subse-
quent loss of acini from the Matrigel surface, culture dishes were maintained at 37 C between
all protocol steps. The exchange of buffers and staining solutions was accomplished using a mi-
cropipetter to minimize disruption of the Matrigel. Antibodies against activated caspase-3 were
acquired from Cell Signaling (Asp175, 5A1E), while anti-E-cadherin antibodies were obtained
from Transduction Laboratories (C20820). Alexa Fluor 488 labeled goat anti-rabbit and Alexa
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Fluor 568 labeled goat anti-mouse (Invitrogen) were used to counterstain the caspase-3 and
E-cadherin antibodies, respectively. Alexa Fluor 568 labeled phalloidin was purchased from
Invitrogen to label F-actin. DAPI (4’,6-diamidino-2-phenylindole) was obtain from Sigma and
diluted for use.
Immunofluorescence controls were carried out for both caspase-3 and E-cadherin staining.
In these control experiments, the same staining protocol was used, but the primary antibody
incubation was replaced by a mock incubation in blocking buffer. The fluorescence-tagged
secondary antibody was then added as normal following the mock incubation. For both the E-
cadherin and caspase-3 controls, only a weak, poorly localized staining pattern was observed.
The fluorescence intensity of the controls were found to have an average fluorescence intensity
level one order of magnitude less than what was observed normally.
In order to image acini before staining with OCT and after staining with two-photon mi-
croscopy, a large 1.25X image of the culture dish surface was taken using a Zeiss 100TV in-
verted cell microscope equipped with a SPOT RT Slider camera (Diagnostic Instruments). This
image was used as a map of the culture dish so that acini could be re-imaged following the 36
hour staining process.
2.6. Chemotherapy treatment
The most effective chemotherapeutic agents against epithelial ovarian cancer have been based
on cytotoxic platinum compounds [1], such as the front-line chemotherapeutic agent CISplatin
[1]. This drug interferes with the cells DNA replication process, effectively targeting fast-
growing cancer cells. CISplatin is clinically administered either intravenously or, more recently,
intraperitoneally (i.p). To simulate i.p administration of CISplatin using the three-dimensional
ovarian cancer model, CISplatin (APP Pharmaceuticals) was added to the 2% Matrigel cell me-
dia just prior to the time-lapse imaging session. The CISplatin dose was calculated from the
maximum i.p. therapeutic dose of 100 mg/m2 used clinically [21], taking into account the area
of the 35 mm culture dish.
2.7. Data and image processing
OCT images were acquired from a rectangular imaging region with a width to height ratio
of 1:2. Ultrahigh resolution OCT volumes were streamed to the RAID, with a single volume
comprising of 2048 (x pixels) x 250 (y pixels) x 2048 (spectral pixels) 10-bit values, resulting
in about 2 GB of data per volume. To allow for long-term data collection and to reduce the post-
processing load, time lapse volumes were acquired using a reduced y axis pixel count of 60 and
reduced width to height aspect ratio of 1:6, resulting in about 450 MB of data per volume. At
an acquisition rate of 2 volumes per hour, the time-lapse OCT system generates nearly 22 GB
of data per day.
Data collected in the OCT experiments was processed using Matlab. Time-lapse movies were
initially created in Matlab and later modified using ImageJ. Two-photon images and stacks were
processed using ImageJ.
3. Results
3.1. Imaging acinar growth and composition
Immediately after seeding, early ovarian cancer acini have been observed to form through a
combination of proliferation and fusion, via the migration and coalescence of individual cells
as well as entire acini [10]. Figure 2 shows representative images from the later stages of acinar
growth and development captured by the ultrahigh resolution SD-OCT system. After ten days
of incubation, ovarian cancer cells form solid spherical structures that sit on top of the gel
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Fig. 2. OCT B-scans of acinar growth. After 10 days of growth (a) (Media 1) acini appeared
as small, solid structures which continue to grow larger by day 13 (b) (Media 2). Internal
structure appeared on day 17 (c) (Media 3) as the acini begin to hollow. By three weeks of
growth (d) (Media 4), the developing acini were hollow, luminal structures full of highly
scattering, loosely packed bodies. Each B-scan links to a movie showing a transverse scan
through a 2 mm x 1mm x 360 µm volume.
matrix (Fig. 2(a)). The varying height of these acini above the coverslip reflect the rough surface
topography of the underlying Matrigel bed, which can be several hundreds of microns thick.
Acini at this stage of growth are already quite large, with average diameters at approximately
100 µm. Unlike their far smaller breast cancer counterparts [9], ovarian cancer acini were
not observed to undergo growth arrest, and continued to increase in size. By thirteen days of
growth, acini can reach up to 300 µm in diameter. Beyond this time point, a subpopulation of
acini remained solid spheroids and continued to slowly grow. The remaining acini, however,
followed a more complex trajectory, first developing a hollow center near 17 days of growth
(Fig. 2(c)) with loose scattering bodies visible in the hollow centers. By three weeks of acinar
growth, the acini developed a luminal structure resembling bubbles filled with debris (Fig. 2(d)).
The luminal appearance of these late-growth acini resembles luminal bodies found in advanced
stage ovarian metastatic lesions in a murine model for disseminated ovarian carcinomatosis
[7]. This finding indicates that the in vitro 3D model replicates the metastatic growth patterns
observed in vivo, and could have biological relevance to human disease. As can be seen from
the temporal progression, the developing acini grow and fuse into each other, resulting in the
elongated, merged structures observed in later growth stages. These complex structural features,
which span up to 1 mm in size, were only first observed during OCT imaging.
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Fig. 3. Direct comparison between live OCT images and stained two-photon fluorescence
images of ovarian cancer acini at different time points. All images are 4 µm thick projec-
tions taken at the acini centers. DAPI appears in blue, while Alexa568-phalloidin labeled
actin is shown in red. A Day 13 acinus visualized with OCT (a) and two-photon fluores-
cence microscopy (d) shows a densely packed cellular structure. The hollow center seen in
a day 17 acinus captured by OCT (b) matches the structure visualized using fluorescence
staining (e). The thin walls of three-week old acini seen in OCT (c) are revealed to be
composed of a layer of cells (f).
In order to understand the structural evolution of the ovarian cancer acini, the structural data
collected using OCT was directly compared to the standard methodology in acini characteriza-
tion, fluorescence microscopy. The contrast in OCT is derived from scattering in the sample,
which can arise from numerous biological features, including cell nuclei, protein layers, and
interfaces. In order to visualize the cellularity of the acinar structures, cultures of ovarian acini
were plated and grown to 13, 17, and 21 days. First visualized with OCT in vitro, the samples
were then immediately fixed and stained with DAPI and Alexa568-phalloidin, to visualize cell
nuclei and the actin cytoskeleton, respectively. Figure 3 shows a direct comparison between
living acini first imaged with OCT and the same, stained acini visualized using two-photon
microscopy. The figure presents a single horizontal projection 4 µm thick through the center
of each acinus in both the OCT and two-photon volumes for structural comparison. At 13 days
of growth, the acinus is composed of closely packed cells with only small unfilled regions in
the acinus center (Fig. 3(d)) marked by actin staining (Fig. 3(d) arrow). The densely packed
cancer cells with large nuclei scatter light strongly, giving rise to the contrast observed in the
OCT image. By day 17, a hollow center can be seen in both OCT and two-photon images (Figs.
3(b) and 3(e)), and small, DAPI-stained bodies can be observed in the acinus center in the fluo-
rescence image (Fig. 3(e) arrow). The shape of these bodies appear fragmented, indicating that
the cells may have undergone apoptosis [22]. By three weeks of growth, the thin outer layer of
the acinus observed in OCT is shown to be composed only of a layer of cells (Figs. 3(c) and
3(f)). The numerous actin-lined regions devoid of cells observed in the fluorescence images (in
red) do not appear in the OCT data (Figs. 3(d) and 3(f) arrows), most likely due to the lower
lateral resolution compared to the two-photon imaging system. Differences between the sets of
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images, such as the appearances of neighboring acini in the fluorescence images, are the result
of fixation and staining artifacts. Other artifacts include changes in acinar shape, acinus de-
tachment from the Matrigel surface, and significant changes to the Matrigel surface itself. The
structural data collected by OCT shows the true state of the acini, as it was collected without
any sample preparation or processing when the acini were still viable.
To confirm the cellular debris observed in the acini centers arise from apoptosis, acini were
grown and stained for activated caspase-3, a key factor in the cellar apoptosis signaling pathway.
Cells that are undergoing or have completed apoptosis will stain positive for the activated form
of caspase-3. Figure 4 shows two similarly sized acini, one grown for 13 days, the other for 17
days, stained for activated caspase-3 and E-cadherin, a cell-cell adhesion protein. These figures
show a 4 µm projection through the center of each acinus. In the early stages of acinar growth
(Fig. 4(a)), only a few apoptotic bodies were observed within the entire acinus volume, and
were distributed randomly throughout the spherical structure. By day 17, numerous apoptotic
bodies appeared predominantly in the hollowing center (Fig 4(b)). The appearance of these
bodies, both in time and in spatial location, matches the debris found to accumulate in large
numbers at the bottom of the acinus by three weeks (Fig. 2(d)). It is interesting to point out that
not all cells found in the hollow acinar center stain for activated caspase-3. This may indicate
that cells first enter the luminal space, and then undergo apoptosis in response to a lack of
cellular survival signals [23].
Day 13 Day 17
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Fig. 4. Ovarian cancer acini stained for activated caspase-3 (red) and E-cadherin (green). As
a cell-cell adhesion molecule, E-cadherin can be seen outlining cellular contacts through-
out the acini. Before acinar hollowing, very few apoptotic cells were observed, and were
distributed randomly throughout the acinus volume (a). Following hollowing, cells in the
luminal space begin undergo apoptosis (b), leading to the eventual filling of the luminal
space with apoptotic bodies.
If the acini are allowed to grow for extended periods of time, the hollowing process leads
to the formation of acini composed of a single cellular layer about the spheroid circumference,
filled with apoptotic debris settled into the lower half of the acinus. This single wall of cells
stains strongly for E-cadherin, which may serve to hold the structure together. The large volume
imaging capabilities of OCT are able to easily visualize the three-dimensional structure of later
stage acini, which grew to nearly 1.5 mm in diameter.
3.2. Time-lapse OCT imaging of acinar structural development
To understand how these complex structures form, a time-lapse OCT system was built to con-
tinuously follow the acinar structural evolution. As a non-perturbative, volumetric imaging
technique, OCT is uniquely capable of capturing the long-term, three-dimensional structural
dynamics of acinar development. Time-lapse OCT differs from the standard fixation/staining
approaches used in these in vitro model experiments, where dynamics are typically inferred by
analyzing temporal snapshots. The lower bandwidth Broadlighter light source was used in this
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experiment, providing a stable broadband spectrum over the course of 110 hours of continuos
imaging. Figure 5 shows a time-lapse OCT movie built from volumes recorded every hour, re-
vealing the nature of the structural changes occurring between 13 to 17.5 days of growth. The
two large acini in the cross section both begin hollowing, with acinus C initiating structural
changes almost a day after acinus A. The sinking of the acini in the movie is due to both long-
term drift of the microscope stage over the course of the multi-day experiment and the thinning
of the Matrigel bed.
Acinus A was observed to initially form a hollow center, suggesting that, through a combina-
tion of growth and migration, cells at the acinar core first migrated away from the core towards
the outer surface by day 16. This observation agrees with the day 17 DAPI and caspase-3 stain-
ing results, which showed only a minimal amount of apoptotic bodies at the acinar center. After
the formation of the initial hollow core, the small segments of the inner acinar walls are ob-
served to shed off into the luminal center. These cellular flakes collected in the bottom half
of the acinus, generating the numerous, loosely packed apoptotic bodies seen with OCT and
multiphoton imaging in Figures 2 and 4. As large chunks of cells are observed to break off into
the hollow center, the time-lapse OCT movie demonstrates that this shedding process is also
responsible for the thinning of the acinar walls with time.
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Fig. 5. (Media 5) Time-lapse OCT movie of acinar growth and development. Two neigh-
boring B-scans were averaged.The movie runs for 92 hours, beginning on day 13 of growth.
The camera was run at a rate of 3076 Hz for an integration time of 325 µs per A-line. Vol-
umes were collected continuously, with a full 2 mm x 1 mm x 1.6 mm volume recorded
every hour. Three acini are labeled in the figure, here called “A”, “B”, and “C”.
Time-lapse OCT also enables the visualization of rare dynamics not possible with standard
fix-and-stain methods, such as the migration and fusion of two acini. Acinus A in Figure 5 is
initially flanked by acinus B, a small, slow-growing solid acinus nearly one fifth its diameter. As
the acini develop, the small acinus migrates toward acinus A, and over the course of 40 hours,
merges and fuses into the large structure. These migration events do not seem to be due to
simply random motion, and have been observed to be directed towards select acini [10], perhaps
due to chemotaxis. The fusion of both acini resulted in a single spheroid, strongly suggesting
that the cells in both acini must be highly motile and able to undergo rapid migration within
the solid structure. Understanding the nature of such events may provide important information
about in vivo ovarian metastatic growth.
3.3. Longitudinal visualization of chemotherapy treatment response
In addition to giving insights into growth and development, the three-dimensional ovarian
cancer models provide a powerful platform for modeling tumor chemotherapeutic response.
#108229 - $15.00 USD Received 2 Mar 2009; revised 23 Apr 2009; accepted 27 Apr 2009; published 12 May 2009
(C) 2009 OSA 25 May 2009 / Vol. 17,  No. 11 / OPTICS EXPRESS  8902
250 !m
Fig. 6. (Media 6)Time-lapse OCT movie of acinar treatment with CISplatin. Two neighbor-
ing B-scans were averaged. The movie runs for 81 hours, beginning on day 13 of growth.
The camera was run at a rate of 1081 Hz for an integration time of 925 µs per A-line.
Volumes were collected continuously, with a full 2 mm x 1 mm x 1.6 mm volume recorded
every 30 minutes.
Ovarian micrometastatic lesions are difficult to detect in vivo, let alone monitor pre- and post-
treatment. As this model was created with the end goal of better understanding ovarian treat-
ment response, the volumetric, non-perturbative longitudinal imaging provided by OCT is an
ideal approach for visualizing large-scale therapeutic effects. Figure 6 shows the impact of a
single clinical dose of one of the most common chemotherapeutic agents for ovarian cancer,
CISplatin, on the ovarian cancer model. During the first 24 hours of treatment, the acini are
observed to slow in growth, and did not start developing hollow centers. This result correlates
well with the mechanism of CISplatin, which interferes with DNA replication by cross-linking
strands of DNA [24], shutting down the cells’ ability to grow and develop.
At the end of 24 hours in the OCT time-lapse movie, numerous small vacuoles were seen to
appear in the acini just prior to the major structural breakdown observed at hour 36. The outer
walls of the acini lost their solid packing, and began to slowly shed away from the structures.
Both large and small acini showed similar structural transformation. As the movie progresses,
the outer layers of cells continued to flake away from the acini structures. By 81 hours of drug
exposure, the smaller acini were observed to completely decay, while the two leftmost acini
retained some structure, with decaying masses surrounding what appeared to be remaining
solid bodies.
Immediately following OCT imaging, the cell culture dish was processed and stained with a
Live/Dead assay to show the status of the ovarian acini. As expected from the time-lapse OCT
movie, the smaller acinar structures contained mostly dead cells, stained by ethidium bromide
dye. The two large leftmost acini, on the other hand, were found to contain living cores that
survived the treatment (Fig. 7), stained in bright green by the cleavage of the Calcein Green AM
ester in the cells’ cytoplasm. The ability to follow the treatment dynamics and visualize living
structures with OCT should allow for more advanced studies in drug screening experiments.
4. Discussion
The structural evolution observed in these ovarian cancer acini has been classically observed
in MCF-10A 3D breast cell models [23]. In these far smaller spherical bodies (about 40 µm in
diameter) the hollowing process has been linked to apoptosis of cells at the acinus center to form
glandular structures reminiscent of the terminal end buds of mammary ducts. The hollowing
ovarian cancer acinar structures observed here most likely result from a combination of growth,
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Fig. 7. CISplatin treated ovarian cancer acini can survive the chemotherapeutic regimen.
Two acini from the time-lapse movie in Figure 6 before treatment (a) and after treatment
(b), and their z-projections (c), and (d), respectively. Following treatment, both acini display
solid, spherical structures (blue circles in (d)) that are revealed to be the surviving acinar
cores using the Live/Dead viability assay (e). Viable cells show green fluorescence from
cleaved Calcein Green AM, while dead cells are are shown in red, stained by Ethidium
bromide. Many of the dead cells seen in (d) were lost during the staining process, resulting
in the few dead cells observed in (e).
migration, and cell death. Cells at the center of the hollowing acinus may become loosely
bound to their neighbors due to down-regulation of surface adhesion proteins [25]. When these
cells break off into the acinar core, they lose their cell-cell contacts and subsequently undergo
apoptosis in response to a lack of cell-cell and cell-matrix survival signals [26], creating the
numerous apoptotic bodies that fill the luminal structure.
The flaking off of cells from the inner acinar walls observed with time-lapse OCT is sugges-
tive of the shedding process seen in epithelial ovarian cancer. Cancer cells flake off the surface
of primary ovarian cancers into the peritoneal cavity, and form metastatic lesions on surfaces in
the peritoneum [25]. If the cells shedding into the acinar core are the result of a similar cellular
signaling cascade, the structural evolution in these late acini may be used to model ovarian peri-
toneal metastasis. A study investigating this process is already underway, using a combination
of OCT and multiphoton imaging.
The SD-OCT imaging system in this study utilized an ultrabroadband light source centered
at 800 nm. The use of light at this wavelength was seen to affect the ultimate penetration depth
of the system in a few cases. While better imaging depths could be obtained using swept-source
OCT systems at 1060 nm or 1300 nm, the current generation of these light sources may not be
able to maintain a stable, consistent spectrum continuously for the many days needed in time-
lapse experiments. Additionally, few light sources offer bandwidths close to 200 nm. As can be
observed between the time-lapse and ultrahigh resolution OCT images, higher axial resolution
is better for cellular-level imaging in these model studies. While a broadband SD-OCT system
was ideal for this study, emerging stable broadband light sources deeper in the infrared will
significantly enhance three-dimensional tumor model imaging.
Optical coherence tomography, with its ability to rapidly visualize large structures with cellu-
lar resolution, clearly has the potential to provide new insights in the field of three-dimensional
cancer models. Widefield imaging techniques cannot follow the complex growth dynamics,
limiting studies of 3D models to 2D observations. Currently used 3D imaging methods, such as
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confocal or multiphoton microscopies, require the slow process of taking depth-resolved stacks
to visualize three-dimensional structures, and typically can only be used to capture snapshots of
development due to the fixation step needed for staining. Even when dyes compatible with live
cell imaging are available, fluorescent labels can be perturbative. Moreover, the depth penetra-
tion of these fluorescence imaging techniques limits them to smaller objects below 500 or 600
µm in size. Confocal reflectance imaging, which can provide high resolution structural imag-
ing deep in samples, still is limited by the time required to collect depth stacks. In contrast, the
ability of OCT to collect volumes at high rates allowed for rapid surveying and characterization
of hundreds of ovarian acini on a single dish in just minutes. A video-rate confocal microscope
with comparable axial resolution to the system used in this work would still be nearly an order
of magnitude slower than OCT in acquiring the same volume.
At the same time, it is important to point out the trade-offs inherent in using optical coherence
tomography as an platform for in vitro model imaging. While the strength of OCT is its capa-
bility to optically image deep in samples nonperturbatively and without labels, the contrast in
OCT is based on index of refraction changes along the optical path. Therefore, standard imple-
mentations of OCT do not have the capability of visualizing samples with molecular selectivity.
While there has been some pioneering work in visualizing molecular information with OCT,
most notably by Boppart and his colleagues [27, 28, 29], OCT remains, in practice, a struc-
tural imaging platform. Another trade-off in OCT is the choice between lateral resolution and
depth of field. Since the axial resolution is dependent on the bandwidth of the light source, it is
essentially decoupled from the constraints of optical system. Thus, unlike the case in standard
microscopic techniques, high numerical aperture lenses are not required for high axial resolu-
tion. Instead, the choice of numerical aperture dictates how much of the optical path through
the sample will be in focus to yield strong backscattered signal. OCT can take advantage of
the large depth of field afforded by lower NA lenses to provide large volume imaging, as was
done in this study. A numerical aperture of .15 was chosen to enable strong OCT signal along
nearly 1 mm of the optical axis, allowing for the full visualization of even the largest acini. With
low numerical apertures, however, comes reduced lateral resolution and the inability to resolve
subcellular details. In this study, the lateral resolution of approximately 7 µm was acceptable
for imaging acini composed of dozens of cells, and was still less than the size of the cells
themselves (about 15 µm). The requirements of individual experiments will dictate the needed
system parameters; in this work the nonperturbative, label-free structural contrast of OCT with
a high depth of field was critical for both long term visualization and quickly surveying the
thousands of acini that can grow on a single plate.
The rapid surveying capability is critical for 3D tumor models to achieve their ultimate use-
fulness as high-throughput drug screening and therapeutic monitoring models. The majority of
studies on drugs and their effects are so far conducted on monolayer cell cultures, which lack
many of the three-dimensional cellular and extracellular cues known to be involved in drug
uptake and resistance. This deficiency can result in poor drug screens that do not accurately
measure efficacy and other critical parameters. Animal models are too costly and time consum-
ing for large-scale pharmaceutical screening, with complexity that can hinder detailed studies
of drug effects. The differential drug response seen between large and small acini captured
by time-lapse OCT in this study demonstrates the ability to visualize the long-term effects of
therapeutics. This imaging approach could be easily scaled to allow for high-throughput, three-
dimensional screening of tens of thousands of acini in a single therapeutic study.
5. Conclusion
Optical coherence tomography can be a powerful imaging technique for the visualization of
three-dimensional cultures of cancer. The large size, imaging depth, and structural complexity
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of spheroid and acini models can be rapidly imaged using OCT for high throughput studies.
Most importantly, the non-perturbative nature of OCT makes it ideal for long-term time-lapse
studies of tumor nodules growth and structural development. When combined with comple-
mentary molecular imaging technologies, OCT is capable of providing new insights into the
biology of these model cancer systems, and ultimately cancer itself.
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